Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Concentrix Corporation (NASDAQ: CNXC) SEC filings page on Stock Titan provides access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. As a Fortune 500 public company, Concentrix uses SEC reports to communicate details about its financial performance, risk factors, capital structure, and significant corporate events.
Among the key filings, investors typically review annual reports on Form 10-K and quarterly reports on Form 10-Q to understand revenue trends, operating income, non-GAAP measures referenced in earnings releases, cash flow, and segment information. Current reports on Form 8-K, such as those furnished for quarterly earnings announcements, give timely updates on results of operations and financial condition, and may include press releases as exhibits.
For those tracking ownership and governance, Forms 3, 4, and 5 (if available) can be used to monitor insider transactions by directors, officers, and significant shareholders. Proxy statements on Schedule 14A, when filed, typically provide information on executive compensation, board structure, and matters submitted to shareholder votes.
On Stock Titan, Concentrix filings are supplemented with AI-powered summaries that explain the main points of lengthy documents in clear language. Real-time updates from the EDGAR system help users see new CNXC filings as they appear, while AI-generated highlights make it easier to identify sections related to non-GAAP metrics, AI and technology investments, and other topics emphasized in the company’s earnings materials. This page is a useful starting point for anyone researching Concentrix’s regulatory history, financial reporting practices, and material disclosures.
Concentrix Corp’s Chief Financial Officer, Valentine Andre S, reported a small stock disposition. On January 27, 2026, the CFO disposed of 278 shares of common stock at $41.61 per share, coded as transaction type “F.”
After this transaction, the filing shows the CFO directly beneficially owning 87,124 shares of Concentrix common stock. The filing is a routine Form 4 insider ownership update and does not describe any additional transactions or derivative securities activity.
Concentrix Corp executive Jane Fogarty, EVP, Legal, reported a small change in her holdings of Concentrix common stock. On January 27, 2026, she disposed of 168 shares of common stock at a price of
Concentrix Corporation files its annual report describing a large, global customer experience and digital operations business serving more than 2,000 clients, including over 160 Fortune Global 500 brands. The company delivers end-to-end CX, analytics, AI-enabled and agentic AI services across 74 countries and multiple industries.
Concentrix highlights growth via major acquisitions such as Webhelp and SAI Digital, and the launch of its Intelligent Experience (iX) AI product suite. The report also outlines key risks, including macroeconomic pressures, cyberattacks, rapid AI-driven technology change, regulatory complexity, and the need to attract and retain skilled staff worldwide.
Concentrix Corp President and CEO Christopher A. Caldwell reported two share disposals of company common stock. On January 24, 2026, he disposed of 10,105 shares at $43.22 each. On January 26, 2026, he disposed of 1,751 shares at $42.69 each.
After these transactions, Caldwell directly beneficially owned 363,772 shares following the first transaction and 362,021 shares following the second transaction, reflecting his remaining direct common stock holdings in Concentrix Corp.
Concentrix Corp Chief Financial Officer Valentine Andre S reported two dispositions of Concentrix common stock. On January 24, 2026, 1,994 shares were disposed of at $43.22 per share, leaving 87,566 shares beneficially owned directly. On January 26, 2026, 164 shares were disposed of at $42.69 per share, leaving 87,402 shares of common stock held directly after the reported transactions.
Concentrix Corp executive Cormac J. Twomey, EVP, Global Ops & Delivery, reported two transactions in Concentrix common stock. On 01/24/2026, 2,893 shares were disposed of at $43.22 per share, and on 01/26/2026, 292 shares were disposed of at $42.69 per share. After these Form 4 reportable events, Twomey directly beneficially owned 58,669 shares of Concentrix common stock.
Concentrix Corp executive Gibson Craig reported a routine share disposition. On 01/24/2026, Craig, EVP, Global Sales, Acct Mgmt, disposed of 1,625 shares of Concentrix common stock at $43.22 per share. After this transaction, he directly beneficially owned 54,398 common shares.
Concentrix Corp executive Jane Fogarty reported routine share transactions in company stock. As EVP, Legal, she reported two non-derivative transactions in Common Stock coded "F" on January 24, 2026 and January 26, 2026.
The first transaction involved 1,319 shares at $43.22 per share, leaving her with 31,725 shares directly owned afterward. The second involved 105 shares at $42.69 per share, after which she directly owned 31,620 shares. All reported holdings are listed as directly owned.
Concentrix Corp reported that President and CEO Christopher A. Caldwell received an equity award in the form of restricted stock units. On 01/21/2026, he was granted 93,291 shares of common stock at a price of $0 per share, increasing his directly held beneficial ownership to 373,877 common shares after the award.
The filing explains that these 93,291 units are restricted stock units granted under the company’s 2020 Stock Incentive Plan. The units are scheduled to vest in three equal installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date, tying the CEO’s compensation to the company’s long‑term performance.
Concentrix Corp executive Jane Fogarty, EVP, Legal, reported an equity award of common stock on a Form 4. On January 21, 2026, she acquired 13,913 shares of Concentrix common stock at a price of $0 per share, reflecting a grant of restricted stock units under the company’s 2020 Stock Incentive Plan.
The restricted stock units vest in three equal installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date. Following this award, Fogarty beneficially owns 33,044 shares of Concentrix common stock directly.